Clinical trial
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis - Assessment of Mechanism of Action
NCT04450030 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis - Assessment of Mechanism of Action
- Lead sponsor
- University Hospital Muenster
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2018
- Completion date
- December 31, 2020
- Enrollment
- 204 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.